Inge Jeding-Jansen possesses extensive expertise in pharmacovigilance and global safety, currently serving as Head of Global Safety & Pharmacovigilance - Senior Director at ALK since May 2022. Previously, Jeding-Jansen held prominent roles at LEO Pharma as Head of Global Safety Surveillance Marketed Products, and at A-consult A/S as Head of Pharmacovigilance & Product Safety. Other significant positions include leading Global Patient Safety at Allergan, serving as Vice Chairman for the Safety & Pharmacovigilance Group at Medicines for Europe, and holding director-level roles at Actavis and Lundbeck. Jeding-Jansen's educational background includes a Postgraduate Certificate in Pharmacovigilance and degrees in Human Biology and Pharmacy from Københavns Universitet and the University of Hertfordshire.
This person is not in any teams
This person is not in any offices